Trump Targets Pharmacy Benefit Managers to Lower Drug Costs

January 17, 2026 - 11:40

President Donald Trump has unveiled a new healthcare plan aimed at reducing prescription drug prices by targeting pharmacy benefit managers (PBMs). In a bold move, he announced intentions to eliminate the kickbacks that these intermediaries receive, which are often passed on to consumers in the form of higher drug prices and insurance premiums.

The plan seeks to enhance transparency in the pharmaceutical supply chain and ensure that savings are directly passed on to patients. Trump emphasized that this initiative is crucial for making healthcare more affordable for American families. By addressing the role of PBMs, the administration hopes to create a more competitive market that benefits consumers rather than profit-driven middlemen.

This announcement comes amid ongoing discussions about the rising costs of healthcare and the need for reform. The proposed changes are expected to resonate with voters who are increasingly concerned about the affordability of their medications and overall healthcare expenses.